| Description |
Knowledge and understanding gained through advances in biotechnology can be leveraged in biodefense research to protect humans and animals against intentional use of pathogens. This conference will present the latest research and technologies to improve specificity, sensitivity, and speed for detecting, identifying, and characterizing pathogens. It will also address efforts to create novel vaccines and therapeutics, to characterize host cell response and stimulate innate immunity, and to develop effective decontamination methods.
SCIENTIFIC ADVISORS AND CHAIRS
Dr. Steven Kornguth, University of Texas at Austin
Dr. Arthur M. Krieg, Coley Pharmaceutical Group
Dr. James D. Marks, University of California, San Francisco
Dr. Lloyd J. Whitman, U.S. Naval Research Laboratory
OVERVIEW
Dr. J. Patrick Fitch, Lawrence Livermore National Laboratory
Dr. Steven Kornguth, University of Texas at Austin
Dr. Gerald McDonnell, STERIS Corporation
Dr. Glen T. Nakafuji, Lawrence Livermore National Laboratory
Mrs. Sue Payton, U.S. Department of Defense
Dr. Davin M. Potts, United Devices, Inc.
DETECTING AND CHARACTERIZING BIOLOGICAL AGENTS
Dr. Carol Fierke, University of Michigan
Dr. Charles Lieber, Harvard University
Dr. Valery A. Petrenko, Auburn University
Dr. Linda Powers, Utah State University
Dr. Lloyd J. Whitman, U.S. Naval Research Laboratory
CHARACTERIZING HOST CELL RESPONSE AND STIMULATING INNATE IMMUNITY
Dr. Emilio Garcia, Lawrence Livermore National Research Laboratory
Dr. C. Fred Battrell, Micronics, Inc.
Dr. Dennis Klinman, U.S. Food and Drug Administration
Dr. Arthur M. Krieg, Coley Pharmaceutical Group
Dr. Anders Sjöstedt, Umeå University
DEVELOPING VACCINES AND THERAPEUTICS
Dr. Karl Y. Hostetler, University of California, San Diego
Dr. S. Benjamin Hua, Genetastix Corporation
Dr. James D. Marks, University of California, San Francisco
Dr. Willem (Pim) Stemmer, Maxygen, Inc.
Dr. Kathryn Sykes, Eliance Biotechnology, Inc.
|
|
